Affiliation:
1. Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128
Abstract
The current development of potent antifungal drugs necessitates reliable methods of in vitro susceptibility testing of clinical isolates. Other laboratories have noted with some antimicrobials that conventional tube dilution visual end points for determining minimal inhibitory concentrations (MIC) vary markedly with the inoculum. With seven isolates (four species) we compared the conventional method with one developed with a spectrophotometer. Yeasts were diluted to inocula of 10
2
to 10
5
cells/ml and incubated at 37°C with 5-fluorocytosine or miconazole or without drug in a synthetic defined medium. At frequent intervals MICs were determined by the lowest drug concentration without visible turbidity. Concurrently, the percent transmission of each tube was measured and an inhibitory concentration (IC
½
) was calculated from the turbidimetric measurements. MICs of both drugs for all strains varied with the inoculum. Intrastrain differences averaged 128-fold for miconazole and greater than 8-fold with 5-fluorocytosine. This variability in MIC occurred when readings were made after 12 to 48 h of incubation. In contrast, IC
½
values of all isolates varied less than two-fold with the same range of inocula. Most isolates showed this independence when measured at 48 h. Fast-growing yeasts showed greater IC
½
variability unless the turbidimetric measurements were taken earlier while the drug-free growth was still in a rapid growth phase. This method is reproducible, inoculum independent, rapid, free from subjectivity and observer variability, and suitable for adaptation to a clinical setting.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference10 articles.
1. Bennett J. E. 1967. Susceptibility of Cryptococcus neoformans to amphotericin B p. 405-410. Antimicrob. Agents Chemother. 1966.
2. Chemotherapy of systemic mycoses;Bennett J. E.;N. Engl. J. Med.,1974
3. A pharmacologic guide to the clinical use of amphotericin B;Bindschadler D. D.;J. Infect. Dis.,1969
4. Variables influencing susceptibility testing ofCryptococcus neoformans to 5-fluorocytosine;Block E. R.;Antimicrob. Agents Chemother.,1973
5. Treatment of fungal meningitis with miconazole;Deresinski S. C.;Am. Rev. Respir. Dis.,1976
Cited by
141 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献